Yervoy Approved for Metastatic Melanoma
Yervoy is a monoclonal antibody that blocks a molecule known as cytotoxic T-lymphocyte antigen (CTLA-4). CTLA-4 may play a role in slowing down or turning off the body's immune system, affecting its ability to fight off cancerous cells. Yervoy may work by allowing the body's immune system to recognize, target, and attack cells in melanoma tumors.
For more information call (800) 321-1335 or visit www.yervoy.com.